The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques
Open accessAbstract
The melanocortin-4 receptor (MC4R) is well recognized as an important mediator of body weight homeostasis. Activation of MC4R causes dramatic weight loss in rodent models, and mutations in human are associated with obesity. This makes MC4R a logical target for pharmacological therapy for the treatment of obesity. However, previous studies in rodents and humans have observed a broad array of side effects caused by acute treatment with MC4R agonists, including increased heart rate and blood pressure. We demonstrate that treatment with a highly-selective novel MC4R agonist (BIM-22493 or RM-493) resulted in transient decreases in food intake (35%), with persistent weight loss over 8 weeks of treatment (13.5%) in a diet-induced obese nonhuman primate model. Consistent with weight loss, these animals significantly decreased adiposity and improved glucose tolerance. Importantly, we observed no increases in blood pressure or heart rate with BIM-22493 treatment. In contrast, treatment with LY2112688, an MC4R agonist previously shown to increase blood pressure and heart rate in humans, caused increases in blood pressure and heart rate, while modestly decreasing food intake. These studies demonstrate that distinct melanocortin peptide drugs can have widely different efficacies and side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Kievit et al [78] reported that administration of another small peptide MC4R agonist, RM-493 (also known as BIM-22493 or setmelanotide), caused transient decreases in food intake (35%) with persistent weight loss and no significant increases in BP or HR over 8 weeks of treatment in a diet-induced obese nonhuman primate model.”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [78]
In the citing paper
“Kievit et al [78] reported that administration of another small peptide MC4R agonist, RM-493 (also known as BIM-22493 or setmelanotide), caused transient decreases in food intake (35%) with persistent weight loss and no significant increases in BP or HR over 8 weeks of treatment in a diet-induced obese nonhuman primate model.”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [78]
In the citing paper
“Kievit et al [78] reported that administration of another small peptide MC4R agonist, RM-493 (also known as BIM-22493 or setmelanotide), caused transient decreases in food intake (35%) with persistent weight loss and no significant increases in BP or HR over 8 weeks of treatment in a diet-induced obese nonhuman primate model.”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001) · Nature · doi:10.1038/35078085 · Cited by 2,356
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., & Cone, R. D. (1997) · Nature · doi:10.1038/385165a0 · Cited by 1,924
Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene
Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E. J., Cheetham, T., & O'Rahilly, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022050 · Cited by 1,778
Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G. E., & Grüters, A. (1998) · Nature Genetics · doi:10.1038/509 · Cited by 1,769
A frameshift mutation in MC4R associated with dominantly inherited human obesity
Yeo, G. S. H., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, R. G., & O'Rahilly, S. (1998) · Nature Genetics · doi:10.1038/2404 · Cited by 1,159
A frameshift mutation in human MC4R is associated with a dominant form of obesity
Vaisse, C., Clément, K., Guy-grand, B., & Froguel, P. (1998) · Nature Genetics · doi:10.1038/2407 · Cited by 1,091
Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates
McCurdy, C. E., Bishop, J. M., Williams, S., Grayson, B. E., Smith, M. S., Friedman, J. E., & Grove, K. L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci32661 · Cited by 614
Integration of NPY, AGRP, and Melanocortin Signals in the Hypothalamic Paraventricular Nucleus
Cowley, M. A., Pronchuk, N., Fan, W., Dinulescu, D. M., Colmers, W. F., & Cone, R. D. (1999) · Neuron · doi:10.1016/s0896-6273(00)80829-6 · Cited by 612
Modulation of Blood Pressure by Central Melanocortinergic Pathways
Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., Astruc, B., Mayer, J. P., Brage, S., See, T. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803085 · Cited by 477
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 230
The melanocortin‐4 receptor pathway and the emergence of precision medicine in obesity management
Fansa, S., & Acosta, A. J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15555 · Cited by 18
Animal Models in Obesity and Hypertension
Segal‐Lieberman, G., & Rosenthal, T. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0338-3 · Cited by 17
Wang, S., Downing, G., Olsen, K. F., Sawyer, T. K., Cone, R. D., & Schwendeman, S. P. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.015 · Cited by 15
Pharmacologic Weight Management in the Era of Adolescent Obesity
Raman, V. S., Gupta, A., Ashraf, A. P., Breidbart, E., Gourgari, E., Kamboj, M. K., Kohn, B., Krishnan, S., Lahoti, A., Matlock, K. A., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac418 · Cited by 15
Mutations in melanocortin-4 receptor: From fish to men
Tao, Y. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.03.003 · Cited by 14
Lazareva, J., Brady, S. M., & Yanovski, J. A. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2199152 · Cited by 15
Beyond satiety: unraveling the complex roles of POMC neurons in behavior and metabolism
Jouque, V., Miralpeix, C., López-Gambero, A. J., Nicolas, J. C., Quarta, C., & Cota, D. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09993-2 · Cited by 17
Qamar, S., Mallik, R., & Makaronidis, J. (2024) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2024.20.2.9 · Cited by 16
The relevance of adhesion G protein-coupled receptors in metabolic functions
Kaczmarek, I., Suchý, T., Prömel, S., Schöneberg, T., Liebscher, I., & Thor, D. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0146 · Cited by 14
Yang, D., Hou, X., Yang, G., Li, M., Zhang, J., Han, M., Zhang, Y., & Liu, Y. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s380577 · Cited by 13
Developments and new vistas in the field of melanocortins
Leone, S., Noera, G., & Bertolini, A. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2015-0023 · Cited by 13
Deletion of the Feeding-Induced Hepatokine TSK Ameliorates the Melanocortin Obesity Syndrome
Wang, Q., Zhang, P., Çakır, I., Mi, L., Cone, R. D., & Lin, J. D. (2021) · Diabetes · doi:10.2337/db21-0161 · Cited by 13
Structural Analysis of Setmelanotide Binding to MC4R Variants in Comparison to Wild-Type Receptor
Hammad, M. M., Mohammad, A., Alam-Eldin, N., Madhu, D., Al‐Mulla, F., Abu‐Farha, M., & Abubaker, J. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120857 · Cited by 12
Understanding the control of ingestive behavior in primates
Wilson, M. E., Moore, C. J., Ethun, K. F., & Johnson, Z. P. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.04.005 · Cited by 13
Salum, K. C. R., de Souza, G. O., Abreu, G. D. M., Campos, M., Kohlrausch, F. B., Carneiro, J. R. I., Neto, J. F. N., Magno, F. C. C. M., Rosado, E. L., Palhinha, L., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.608840 · Cited by 11
Ju, S. H., Yun, H., Oh, Y., Choi, Y., & Sohn, J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111579 · Cited by 11
RISING STARS: Targeting G protein-coupled receptors to regulate energy homeostasis
Jamaluddin, A., & Gorvin, C. M. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-23-0014 · Cited by 12
Management of Monogenic and Syndromic Obesity
Han, J. C., Rasmussen, M. C., Forte, A. R., Schrage, S. B., Zafar, S., & Haqq, A. M. (2023) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2023.08.005 · Cited by 16
Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy
Merlino, D. J., Blomain, E. S., Aing, A., & Waldman, S. A. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3030763 · Cited by 13
Franzago, M., Porreca, A., D’Ardes, M., Nicola, M. D., Tizio, L. D., Liberati, M., Stuppia, L., & Vitacolonna, E. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.879526 · Cited by 11
Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor
Saleh, N., Kleinau, G., Heyder, N., Clark, T., Hildebrand, P. W., & Scheerer, P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00560 · Cited by 11
Melanocortin-4 Receptor Modulators for the Treatment of Obesity: a Patent Analysis (2008–2014)
Lee, E. C. Y., & Carpino, P. A. (2015) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.15.1 · Cited by 10
Do anti-obesity medical treatments have a direct effect on adipose tissue?
Vergès, B. L. (2024) · Annales d Endocrinologie · doi:10.1016/j.ando.2024.05.021 · Cited by 9
Doering, S. R., Freeman, K. T., Debevec, G., Geer, P., Santos, R. G., Lavoi, T. M., Giulianotti, M. A., Pinilla, C., Appel, J. R., Houghten, R. A., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02041 · Cited by 9
Ni, Z., Wang, Y., Shi, C., Zhang, X., Gong, H., & Dong, Y. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-04089-y · Cited by 9
de Carvalho, A. M., Shao, P., Liu, H., Cheng, H.-L., Zheng, Y., Leng, J., Li, W., Huang, T., Wang, T., Wang, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10101-x · Cited by 9
Peripheral actions and direct central–local communications of melanocortin 4 receptor signaling
Li, L., Liang, J., Zhang, C., Liu, T., & Zhang, C. (2021) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2021.02.001 · Cited by 10
Modeling energy intake by adding homeostatic feedback and drug intervention
Gennemark, P., Hjorth, S., & Gabrielsson, J. (2014) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-014-9399-4 · Cited by 8
Stagi, S., Bianconi, M., Sammarco, M. A., Artuso, R., Giglio, S., & de Martino, M. (2017) · InTech eBooks · doi:10.5772/66128 · Cited by 7
Neuroendocrine manifestations of Erdheim–Chester disease
Manaka, K., Sato, J., & Makita, N. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-820683-6.00010-5 · Cited by 8
New hormone treatment for obesity caused by POMC-deficiency
Low, M. J. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.156 · Cited by 8
Effective and appropriate use of weight loss medication in pediatric obesity: a narrative review
Chung, L. Y. (2024) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2024.00353 · Cited by 7
Serrano, J., Casanova‐Martí, À., Blay, M., Terra, X., Pinent, M., & Ardèvol, A. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.08.002 · Cited by 7
Hormone-Replacement Therapy for Melanocyte-Stimulating Hormone Deficiency
Reitman, M. L. (2016) · New England Journal of Medicine · doi:10.1056/nejme1606919 · Cited by 7
Human gain-of-function MC4R variants show signaling bias and protect against obesity
Lotta, L. A., Mokrosiński, J., Mendes de Oliveira, E., Li, C., Sj, S., Luan, J., Brouwers, B., Ayinampudi, V., Bowker, N., Kerrison, N. D., et al. (2020) · Yearbook of pediatric endocrinology · doi:10.1530/ey.17.11.3 · Cited by 10
Gpr149 is involved in energy homeostasis in the male mouse
Wyler, S. C., Surbhi, Cao, N., Merchant, W., Bookout, A. L., & Gautron, L. (2024) · PeerJ · doi:10.7717/peerj.16739 · Cited by 8
Chan‐Ling, T., Hu, P., Calzi, S. L., Warner, J., Uddin, M. N., Dupont, M., Neuringer, M. D., Kievit, P., Renner, L. M., Stoddard, J., et al. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.02.019 · Cited by 6
Robinson, G. N., & Pickering, R. J. (2024) · Diabetology · doi:10.3390/diabetology5010006 · Cited by 6
Shpakov, A. O., & Derkach, K. V. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0426-y · Cited by 6
Pharmaceutical approaches to weight management: behavioural mechanisms of action
Roberts, C. A., Christiansen, P., & Halford, J. C. G. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.04.017 · Cited by 6
Clemence, G., Marks, D. L., & Butler, A. A. (2018) · Obesity · doi:10.1002/oby.22306 · Cited by 6
Anorectic state of obesity medications in the United States. Are leaner times ahead?
Li, X., & Bello, N. T. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1692815 · Cited by 6
Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs)
Weirath, N. A., & Haskell‐Luevano, C. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00129 · Cited by 5
Obesity dysregulates feeding-evoked response dynamics in hypothalamic satiety neurons
Porniece, M., Baker, J., Ausfahl, C. D., Zhang, S. X., & Andermann, M. L. (2025) · Scientific Reports · doi:10.1038/s41598-025-19800-2 · Cited by 5
Kuhre, R. E., Modvig, I. M., Jepsen, S. L., Kizilkaya, H. S., Bæch‐Laursen, C., Smith, C. A., Reimann, F. M., Gribble, F. M., ROSENKILDE, M. M., & Holst, J. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.690387 · Cited by 5
New Perspectives on the Development of Antiobesity Drugs
Costantino, L., & Barlocco, D. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.14.167 · Cited by 5
Hypothalamic γ-melanocyte stimulating hormone gene delivery reduces fat mass in male mice
Eerola, K., Virtanen, S., Vähätalo, L. H., Ailanen, L., Cai, M., Hruby, V. J., Savontaus, M., & Savontaus, E. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0009 · Cited by 5
Wang, J., Xu, F., Liu, Y., Zhou, H., Yuan, W., Liu, F., Ye, F., & Liang, X. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108918 · Cited by 5
Rivera, A., Framnes‐DeBoer, S. N., & Arble, D. M. (2024) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2024.104370 · Cited by 4
The Implications of Maternal Obesity on Offspring Physiology and Behavior in the Nonhuman Primate
Sullivan, E. L., & Kievit, P. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6386-7_10 · Cited by 4
Prindle, C. R., Bennett, T. L., Rajewski, B. H., Kelley, K. J., Impastato, A. C., Potterfield, R., Marks, D. L., & Delev, J. Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1797586 · Cited by 3
Dubern, B., Clément, K., & Poitou, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48559-3.00014-2 · Cited by 3
Setmelanotide in obesity: a profile of its use
Kang, C. (2022) · Drugs & Therapy Perspectives · doi:10.1007/s40267-022-00929-3 · Cited by 3
Current pharmacological approaches in obesity treatment
TİRYAKİOĞLU, P., Yilmaz, H., Demir, İ., & Yilmaz, I. C. (2023) · DAHUDER Medical Journal · doi:10.56016/dahudermj.1271677 · Cited by 4
Simonds, S. E., Pryor, J. T., Lam, B., Dowsett, G. K. C., Mustafa, T., Munder, A. C., Elysee, K., Balland, É., Cowley, L. O., Yeo, G. S. H., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101936 · Cited by 2
Bredum, S. K., Jacobsen, J. M., Cirera, S., & Christoffersen, B. Ø. (2025) · Laboratory Animal Research · doi:10.1186/s42826-024-00233-3 · Cited by 2
Howard, C. J., Abell, N. S., Osuna, B. A., Jones, E. M., Chan, L. Y., Chan, H. W.-S., Artis, D. R., Asfaha, J. B., Bloom, J. S., Cooper, A. R., et al. (2024) · eLife · doi:10.7554/elife.104725.3 · Cited by 26
Seiler, J. L., Impastato, A. C., Zhang, E., Kelley, K. J., Bennett, T. L., Studnitzer, B., Prindle, C. R., Rajewski, B. H., Badeau, B. A., Jiang, X., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73372-x · Cited by 2
Novel melanocortin 4 receptor agonist causes weight loss in obese rhesus macaques
Greenhill, C. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.202 · Cited by 2
Shpakov, A. O., Жарова, О. А., & Derkach, K. V. (2017) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s1234567817020021 · Cited by 2
Blaustein, M. P., & REUTER, H. (2014) · Physiology News · doi:10.36866/pn.96.32 · Cited by 2
Gorvin, C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00020-7 · Cited by 2
Shpakov, A. O., Derkach, K. V., Жарова, О. А., Shpakova, E. A., & Бондарева, В. М. (2015) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747815010079 · Cited by 2
McMillan, T., Forster, M. A. M., Short, L. I., Rudecki, A. P., Cline, D. L., & Gray, S. L. (2020) · Experimental Physiology · doi:10.1113/ep088838 · Cited by 2
Howard, C. J., Abell, N. S., Osuna, B. A., Jones, E. M., Chan, L. Y., Chan, H., Artis, D. R., Asfaha, J. B., Bloom, J. S., Cooper, A. R., et al. (2024) · eLife · doi:10.7554/elife.104725.1 · Cited by 2
Dual Activation of MC3R and MC4R Drives Weight Loss and Reduces Food Intake in Obese PrimatesPreprint
Seiler, J. L., Impastato, A. C., Zhang, E., Kelley, K. J., Bennett, T. L., Studnitzer, B., Prindle, C. R., Rajewski, B. H., Badeau, B. A., Jiang, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.25.690554 · Cited by 2
Duquesnoy, M., Mosbah, H., Clément, K., Dubern, B., & Poitou, C. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.07.002 · Cited by 1
Jacobsen, J. M., & Christoffersen, B. Ø. (2025) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2025.108395 · Cited by 1
Sun, Y., Abed, M., & Sohouli, M. H. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02071-2 · Cited by 1
Recent developments in GPCR signalling in appetite regulation
Brittain, H. R., & Gorvin, C. M. (2026) · Bioscience Reports · doi:10.1042/bsr20250120 · Cited by 1
Translational physiology in practice
Seals, D. R., Santos‐Parker, J. R., & LaRocca, T. J. (2014) · Physiology News · doi:10.36866/pn.96.38 · Cited by 1
Hypothalamic Obesity and Wasting Syndromes
Uwaifo, G. I. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-62187-2_12 · Cited by 1
Melanocortin receptors in GtoPdb v.2023.1
Caruso, V., Chai, B., Clark, A., Cone, R. D., Eberlé, A. N., Farooqi, I. S., Fong, T. M., Gantz, I., Haskell‐Luevano, C., Hruby, V. J., et al. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f38/2023.1 · Cited by 1
Li, P., Ye, H., Guo, F., Zheng, J., Shen, W., Xie, D., Shi, S., Zhang, Y., Fa, Y., & Zhao, Z. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167616 · Cited by 1
Leptin, the Autonomic Nervous System, and Hypertension
da Silva, A. A., do Carmo, J. M., Wang, Z., & Hall, J. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-09915-6_14 · Cited by 1
Al‐Najim, W., le Roux, C. W., & Docherty, N. G. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.003 · Cited by 1
Obesity and Stress: The Melanocortin Connection
Singhal, S., & Hill, J. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-89506-2_11 · Cited by 1
Drug Pipeline for Obesity Therapy
Panicker, A. T., Desai, P. S., Karnik, S. S., & Kumar, M. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_68 · Cited by 1
Melanocortinas y su participación en el desarrollo de la obesidad
López-Alonso, V. E., Díaz‐Urbina, D., Escartín-Pérez, R. E., & Díaz, J. M. M. (2022) · Revista Mexicana de Trastornos Alimentarios/Mexican Journal of Eating Disorders · doi:10.22201/fesi.20071523e.2020.4.643 · Cited by 1
Adjunctive Therapy, Including Pharmacotherapy
Al-Bazz, D. Y., & Wilding, J. P. H. (2022) · Wiley eBooks · doi:10.1002/9781119695257.ch21 · Cited by 1
Howard, C. J., Abell, N. S., Osuna, B. A., Jones, E. M., Chan, L. Y., Chan, H., Artis, D. R., Asfaha, J. B., Bloom, J. S., Cooper, A. R., et al. (2025) · eLife · doi:10.7554/elife.104725.2 · Cited by 1
Huvenne, H., Tounian, P., Clément, K., & Dubern, B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00021-x
Dunn, J. P., & Mittendorfer, B. (2016) · The Journal of Physiology · doi:10.1113/jp272701
Neuropsychopharmacology of appetite in healthy volunteers
Thomas, J. M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Doering, S. R. (2016) · University of Minnesota Digital Conservancy (University of Minnesota)
The Role of the Melanocortin System in Binge-Like Ethanol Consumption
Sprow, G. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/bjny-bv21
Melanocortin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Caruso, V., Chai, B., Clark, A., Cone, R. D., Eberlé, A. N., Farooqi, I. S., Fong, T. M., Gantz, I., Haskell‐Luevano, C., Hruby, V. J., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f38/2019.4
North, R. A., & Karczmar, A. G. (2014) · Physiology News · doi:10.36866/pn.96.46
Obesity – a global health crisis
Brinsden, H. C. (2014) · Physiology News · doi:10.36866/pn.96.9
Boross-Toby, N. (2014) · Physiology News · doi:10.36866/pn.96.20
Are my genes to blame when my jeans don’t fit?
Yeo, G. S. H. (2014) · Physiology News · doi:10.36866/pn.96.12
A round up of obesity-related discussion at IUPS 2013, Birmingham
Wood, C. (2014) · Physiology News · doi:10.36866/pn.96.14
Food fight: new approaches to preventing and treating obesity
Spreckley, E., & Murphy, K. G. (2014) · Physiology News · doi:10.36866/pn.96.28
Coote, J. H., & Egginton, S. (2014) · Physiology News · doi:10.36866/pn.96.44
Eisner, D. A. (2014) · Physiology News · doi:10.36866/pn.96.20a
Vaughan‐Jones, R. D. (2014) · Physiology News · doi:10.36866/pn.96.5
Tailor, A. (2014) · Physiology News · doi:10.36866/pn.96.11
Metadata
- Authors
- Kievit, P., Halem, H., Marks, D. L., Dong, J. Z., Glavas, M. M., Sinnayah, P., Pranger, L., Cowley, M. A., Grove, K. L., & Culler, M. D.
- Affiliations
- Oregon National Primate Research Center (US)
- Ipsen (United States) (US)
- Oregon Health & Science University (US)
- Corresponding author
- Grove, Kevin L.
- Culler, Michael D.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2013-01-17
- Volume
- 62
- Issue
- 2
- Pages
- 490-497
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3554387
- OpenAlex
- W2167727277
- Cited by
- 231
- References
- 45
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 13 · 2023: 16 · 2022: 15 · 2021: 22 · 2020: 14 · 2019: 17 · 2018: 18 · 2017: 16 · 2016: 12 · 2015: 19 · 2014: 36 · 2013: 8
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (OD 011092-53, P51OD011092)
- National Center for Research Resources (P51RR000163)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- melanocortin-4 receptor, MC4R agonist, diet-induced obesity, rhesus monkeys, weight loss, insulin resistance, glucose tolerance, cardiovascular function, blood pressure, heart rate, dietary intake, obesity pharmacotherapy, adverse drug reactions
- MeSH terms
- alpha-MSH, Animals, Blood Pressure, Cardiovascular System, Chronic Disease, Eating, Heart Rate, Insulin Resistance, Macaca mulatta, Male, Obesity, Peptides, Weight Loss, Glucose Intolerance, Anti-Obesity Agents, Receptor, Melanocortin, Type 4, Adiposity, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
